Patterns of resource utilization and cost for postmenopausal women with hormone-receptor–positive, human epidermal growth factor receptor-2–negative advanced breast cancer in Europe

Patterns of resource utilization and cost for postmenopausal women with hormone-receptor–positive, human epidermal growth factor receptor-2–negative advanced breast cancer in Europe

Bibliographic Details
Main Authors:	Jerusalem, Guy, Neven, Patrick, Marinsek, Nina, Zhang, Jie, Degun, Ravi, Benelli, Giancarlo, Saletan, Stephen, Ricci, Jean-François, Andre, Fabrice
Format:	Online
Language:	English
Published:	BioMed Central 2015
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4619560/

Similar Items

Endocrine therapy considerations in postmenopausal patients with hormone receptor positive, human epidermal growth factor receptor type 2 negative advanced breast cancers
by: Migliaccio, Ilenia, et al.
Published: (2015)

Delaying Chemotherapy in the Treatment of Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer
by: Brufsky, Adam M.
Published: (2015)

Treatment challenges for community oncologists treating postmenopausal women with endocrine-resistant, hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer
by: Abdel-Razeq, Hikmat
Published: (2016)

Treatment challenges for community oncologists treating postmenopausal women with endocrine-resistant, hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer
by: Gradishar, William J
Published: (2016)

Surgery Should Complement Endocrine Therapy for Elderly Postmenopausal Women with Hormone Receptor-Positive Early-Stage Breast Cancer
by: Nguyen, Olivier, et al.
Published: (2012)

Conversion of epidermal growth factor receptor 2 and hormone receptor expression in breast cancer metastases to the brain
by: Duchnowska, Renata, et al.
Published: (2012)

Epidermal growth factor receptor (EGFr) status associated with failure of primary endocrine therapy in elderly postmenopausal patients with breast cancer.
by: Nicholson, S., et al.
Published: (1988)

Patients’ preferences and willingness-to-pay for postmenopausal hormone receptor-positive, HER2-negative advanced breast cancer treatments after failure of standard treatments
by: Ngorsuraches, Surachat, et al.
Published: (2015)

Vimentin and p53 expression on epidermal growth factor receptor-positive, oestrogen receptor-negative breast carcinomas.
by: Cattoretti, G., et al.
Published: (1988)

Selective thyroid hormone receptor modulators
by: Raparti, Girish, et al.
Published: (2013)

Postmenopausal hormonal therapy: Current status
by: Jyotsna, V. P.
Published: (2013)

Epidermal Growth Factor Receptor Expression in Triple Negative and Nontriple Negative Breast Carcinomas
by: Changavi, Arathi A, et al.
Published: (2015)

Clinical relevance of the reappraisal of negative hormone receptor expression in breast cancer
by: Pinto, António E, et al.
Published: (2013)

Migraine and possible etiologic heterogeneity for hormone-receptor-negative breast cancer
by: Shi, Min, et al.
Published: (2015)

Correction: Evaluating Serum Markers for Hormone Receptor-Negative Breast Cancer
by: Schummer, Michèl, et al.
Published: (2016)

Corrigendum: Migraine and possible etiologic heterogeneity for hormone-receptor-negative breast cancer
by: Shi, Min, et al.
Published: (2016)

Evaluating Serum Markers for Hormone Receptor-Negative Breast Cancer
by: Schummer, Michèl, et al.
Published: (2015)

Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice
by: Burga, Laura N, et al.
Published: (2011)

Triple-negative breast cancer: treatment challenges and solutions
by: Collignon, Joëlle, et al.
Published: (2016)

Hormone replacement therapy use dramatically increases breast oestrogen receptor expression in obese postmenopausal women
by: Lawson, James S, et al.
Published: (2001)

Association of serum sex steroid receptor bioactivity and sex steroid hormones with breast cancer risk in postmenopausal women
by: Fourkala, Evangelia-Ourania, et al.
Published: (2012)

Efficacy of adjuvant aromatase inhibitor in hormone receptor-positive postmenopausal breast cancer patients according to the body mass index
by: Sendur, M A N, et al.
Published: (2012)

Pharmacologic management of bone-related complications and bone metastases in postmenopausal women with hormone receptor-positive breast cancer
by: Yardley, Denise A
Published: (2016)

Short-term weight gain and breast cancer risk by hormone receptor classification among pre- and postmenopausal women
by: Rosner, Bernard, et al.
Published: (2015)

Effects of CDK4/6 Inhibition in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Cells with Acquired Resistance to Paclitaxel
by: Trapé, Adriana Priscila, et al.
Published: (2016)

The Role of Epidermal Growth Factor Receptor Mutations and Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in the Treatment of Lung Cancer
by: Chang, Shih-Chieh, et al.
Published: (2011)

Oncogenic fingerprint of epidermal growth factor receptor pathway and emerging epidermal growth factor receptor blockade resistance in colorectal cancer
by: Sobani, Zain A, et al.
Published: (2016)

Colocalization of somatostatin receptors and epidermal growth factor receptors in breast cancer cells
by: Watt, Heather L, et al.
Published: (2006)

Interleukin-4 receptor and epidermal growth factor receptor expression in colorectal cancer.
by: Kaklamanis, L., et al.
Published: (1992)

Receptor-mediated endocytosis of epidermal growth factor by rat hepatocytes: receptor pathway
Published: (1986)

Attribution to Heterogeneous Risk Factors for Breast Cancer Subtypes Based on Hormone Receptor and Human Epidermal Growth Factor 2 Receptor Expression in Korea
by: Park, Boyoung, et al.
Published: (2016)

Relationship between body mass index and the expression of hormone receptors or human epidermal growth factor receptor 2 with respect to breast cancer survival
by: Jeon, Ye Won, et al.
Published: (2015)

Evaluation of hormone receptor, human epidermal growth factor receptor-2 and Ki-67 with core needle biopsy and neoadjuvant chemotherapy effects in breast cancer patients
by: Ge, Wen-kai, et al.
Published: (2015)

Hormone replacement therapy and the prevention of postmenopausal osteoporosis
by: Gambacciani, Marco, et al.
Published: (2014)

Endometriosis in a Postmenopausal Woman on Hormonal Replacement Therapy
by: Jeon, Dong-Su, et al.
Published: (2013)

Controversies in the hormonal adjuvant therapy of postmenopausal patients
by: Dowsett, M
Published: (2009)

Melatonin and Female Hormone Secretion in Postmenopausal Overweight Women
by: Walecka-Kapica, Ewa, et al.
Published: (2015)

Hormones, Receptors and Breast Cancer
by: Barnes, D. M.
Published: (1979)

Membrane receptors for hormones and neurotransmitters
Published: (1976)

Nuclear hormone receptors in podocytes
by: Khurana, Simran, et al.
Published: (2012)